MSH Capital Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$35.5M |
| 2 |
Tesla
TSLA
|
+$3.46M |
| 3 |
American Century US Quality Growth ETF
QGRO
|
+$2.51M |
| 4 |
AbbVie
ABBV
|
+$2.04M |
| 5 |
NVIDIA
NVDA
|
+$1.87M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rentokil
RTO
|
+$553K |
| 2 |
Guardant Health
GH
|
+$529K |
| 3 |
Citigroup
C
|
+$477K |
| 4 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$440K |
| 5 |
Seagate
STX
|
+$386K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.1% |
| 2 | Financials | 8.13% |
| 3 | Healthcare | 3.83% |
| 4 | Consumer Discretionary | 3.62% |
| 5 | Consumer Staples | 3.11% |
Similar funds
MSH Capital Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, MSH Capital Advisors held 279 positions worth $468M, up 25% from $373M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
MSH Capital Advisors deployed $89.3M of net new capital in Q4 2025, opening 36 new positions and adding to 164 existing holdings. Its largest new stake was American Century US Quality Growth ETF: 22,014 shares worth $2.52M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 8% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Guardant Health, an estimated $529K trimmed.
- MSH Capital Advisors's largest Q4 2025 buy was American Century US Quality Growth ETF: 22,014 shares worth $2.52M.
- MSH Capital Advisors added most to Apple in Q4 2025, an estimated $35.5M increase.
- MSH Capital Advisors's biggest Q4 2025 reduction was Guardant Health, cutting an estimated $529K.
- MSH Capital Advisors fully exited Rentokil in Q4 2025, selling an estimated $553K.
- MSH Capital Advisors's ten largest holdings make up 29% of its $468M portfolio in Q4 2025.
- MSH Capital Advisors opened 36 new positions and closed 5 in Q4 2025.
- MSH Capital Advisors's portfolio value rose 25% quarter-over-quarter to $468M.
Based on MSH Capital Advisors's 13F filing for Q4 2025, filed 9 Feb 2026.